Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc.verified

ORMP

Price:

$2.39

Market Cap:

$97.44M

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for the treatment of individuals with diabetes. It is also developing ORMD-0901, an oral glucagon-like peptide-1 capsule that has completed phase I clinical trials for the treatment of type 2 diabetes; and a weight loss treatment in the form of an oral leptin capsule. The company was formerly known as Integrated Security Technologies, Inc. and changed its n...[Read more]

Industry

Biotechnology

IPO Date

2007-05-01

Stock Exchange

NASDAQ

Ticker

ORMP

The Dividend Yield as of November 2024 (TTM) for Oramed Pharmaceuticals Inc. (ORMP) is 0%

According to Oramed Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

Oramed Pharmaceuticals Inc. (ORMP) Historical Dividend Yield (quarterly & annually)

How has ORMP Dividend Yield performed in the past?

The mean historical Dividend Yield of Oramed Pharmaceuticals Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), ORMP's Dividend Yield was at its highest in in the November 2013 quarter at 0%. The Dividend Yield was at its lowest in in the November 2013 quarter at 0%.

Quarterly (TTM)
Annual

Average

0%

Median

0%

Minimum

0%

Maximum

0%

Oramed Pharmaceuticals Inc. (ORMP) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of Oramed Pharmaceuticals Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Dividend Yield = 0%

Minimum Annual Increase = 0%

Minimum Annual Dividend Yield = 0%

Quarterly (TTM)
Annual
YearDividend YieldChange
20220%0%
20210%0%
20200%0%
20190%0%
20180%0%
20170%0%
20160%0%
20150%0%
20140%0%
20130%0%

Oramed Pharmaceuticals Inc. (ORMP) Average Dividend Yield

How has ORMP Dividend Yield performed in the past?

The current Dividend Yield of Oramed Pharmaceuticals Inc. (ORMP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

0%

5-year avg

0%

10-year avg

0%

Oramed Pharmaceuticals Inc. (ORMP) Dividend Yield vs. Peers

How is ORMP’s Dividend Yield compared to its peers?

Oramed Pharmaceuticals Inc.’s Dividend Yield is less than Protalix BioTherapeutics, Inc. (0%), less than Corvus Pharmaceuticals, Inc. (0%), less than Aldeyra Therapeutics, Inc. (0%), less than Gamida Cell Ltd. (0%), less than Checkpoint Therapeutics, Inc. (0%), less than BioLineRx Ltd. (0%), less than Ardelyx, Inc. (0%), less than Lexicon Pharmaceuticals, Inc. (0%), less than Seres Therapeutics, Inc. (0%), less than ImmunityBio, Inc. (0%), less than X4 Pharmaceuticals, Inc. (0%), less than Mereo BioPharma Group plc (0%), less than Inozyme Pharma, Inc. (0%), less than Terns Pharmaceuticals, Inc. (0%), less than Leap Therapeutics, Inc. (0%), less than Zura Bio Limited (0%), less than Altamira Therapeutics Ltd. (0%), less than Immix Biopharma, Inc. (0%), less than Enveric Biosciences, Inc. (0%), less than Palisade Bio, Inc. (0%), less than Hepion Pharmaceuticals, Inc. (0%), less than AVROBIO, Inc. (0%), less than CohBar, Inc. (0%), less than Ocean Biomedical, Inc. (0%), less than Elevation Oncology, Inc. (0%),

Build a custom stock screener for Oramed Pharmaceuticals Inc. (ORMP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oramed Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Oramed Pharmaceuticals Inc. (ORMP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Oramed Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Dividend Yield?

How can you use the Dividend Yield?

What is Oramed Pharmaceuticals Inc.'s Dividend Yield?

How is the Dividend Yield calculated for Oramed Pharmaceuticals Inc. (ORMP)?

What is the highest Dividend Yield for Oramed Pharmaceuticals Inc. (ORMP)?

What is the 3-year average Dividend Yield for Oramed Pharmaceuticals Inc. (ORMP)?

What is the 5-year average Dividend Yield for Oramed Pharmaceuticals Inc. (ORMP)?

How does the current Dividend Yield for Oramed Pharmaceuticals Inc. (ORMP) compare to its historical average?